Sign in
Phase I Trial of 5-Day Continuous Infusion Aziridinylbenzoquinone (AZQ, Diazaquone, NSC 182968)
Journal article   Peer reviewed

Phase I Trial of 5-Day Continuous Infusion Aziridinylbenzoquinone (AZQ, Diazaquone, NSC 182968)

Lawrence M Sigman, David A Van Echo, Margaret Y Whitacre, Joseph Aisner, Daniel A Budman and Philip Shulman
American journal of clinical oncology, Vol.9(1), pp.79-82
02/1986
PMID: 3953494

Metrics

Details